December 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreNovember 01, 2025
According to market projections, the single cell sequencing sector is expected to grow from USD 1.63 billion in 2024 to USD 6.65 billion by 2034, reflecting a CAGR of 15.05%. Advancements in sequencing technologies and increased funding for personalized medicine are further driving its expansion....
November 01, 2025
The U.S. residual DNA testing market is growing because increasing application of this testing in forensics and criminal investigations, immigration, infidelity, and paternity....
November 01, 2025
Market insights predict, the digital PCR (dPCR) and real-time PCR (qPCR) industry is expected to grow from USD 10.15 billion in 2024 to USD 21.87 billion by 2034, driven by a CAGR of 7.97%. The digital PCR (dPCR) and real-time PCR (qPCR) market is growing due to rising demand for gene sequencing and the development of gene therapies. North America ...
November 01, 2025
According to market projections, the global exosome research market, valued at USD 191 million in 2024, is anticipated to reach USD 954.03 million by 2034, growing at a CAGR of 17.45% over the next decade. Due to the widespread application of exosomes in many health concerns and technological advances are supporting the overall global market...
November 01, 2025
The growing demand for gene therapy and stringent regulatory policies drive the global market. North America dominated the market due to its favorable clinical trial infrastructure and new product launches....
November 01, 2025
Market insights predict the global cell and gene therapy isolator industry will increase from USD 1.35 billion in 2024 to USD 4.47 billion by 2034, achieving a CAGR of 12.54%. The growing demand for cell and gene therapy products and technological advancements drive the market. North America dominated the global market due to the presence of key pl...
November 01, 2025
Market insights predict, the cell and gene overexpression service industry is expected to grow from USD 771.40 million in 2024 to USD 1,192.24 million by 2034, driven by a CAGR of 4.45%. The cell and gene overexpression service market is expanding due to growing demand for biologics as well as growth in plasmid-based transfection use. North America...
November 01, 2025
Projections indicate that, the global cell & gene therapy (CGT) biomanufacturing market will increase from USD 14.03 billion in 2024 to USD 41.41 billion by 2034, experiencing a CAGR of 11.43% over the next 10 years. Increasing outsourcing & contract manufacturing have driven the growth of the market. North America led the global market owi...
November 01, 2025
Market insights predict, the gene knockdown stable cell line service industry is expected to grow from USD 715 million in 2024 to USD 1557 million by 2034, driven by a CAGR of 8.16%. The market is growing due to the increasing use of stable cell models in drug development, target validation, and functional genomics studies. The strong biotech resea...
November 01, 2025
Based on market forecasts, the global cell and gene therapy tools and reagents market, projected at USD 10.04 billion in 2024, is expected to reach USD 27.3 billion by 2034, growing at a CAGR of 10.76% over the forecast period. The cell and gene therapy tools and reagents market is expanding due to growing CGT clinical trials as well as growing res...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com